Evidence map›Paper›PMID 28858297›Full record

ArticleActa pharmacologica Sinica2018

YL-0919, a dual 5-HT

Yu-Hua Ran, Xiao-Xu Hu, Yu-Lu Wang, Nan Zhao, Li-Ming Zhang, Hua-Xia Liu, Yun-Feng Li

Open access · bronzeAbstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Influence of 5-HTPsychopharmacology · 2021
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. The Antioxidative Action of ZTP by Increasing Nrf2/ARE Signal Pathway.Evidence-based complementary and alternative medicine : eCAM · 2019
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yu-Hua RanDepartment of New Drug Evaluation, State Key Laboratory of Toxicology Medical Courtermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Xiao-Xu HuDepartment of New Drug Evaluation, State Key Laboratory of Toxicology Medical Courtermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Yu-Lu WangDepartment of New Drug Evaluation, State Key Laboratory of Toxicology Medical Courtermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Nan ZhaoDepartment of New Drug Evaluation, State Key Laboratory of Toxicology Medical Courtermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Li-Ming ZhangDepartment of New Drug Evaluation, State Key Laboratory of Toxicology Medical Courtermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Hua-Xia LiuCollege of Nursing, Taishan Medical University, Taian 271000, China.
Yun-Feng LiDepartment of New Drug Evaluation, State Key Laboratory of Toxicology Medical Courtermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Fujian University of Traditional Chinese Medicine · CNTaishan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

YL-0919 has been identified as a novel dual 5-HT

Indexed as

AnimalsAnti-Anxiety AgentsAntidepressive AgentsBrain-Derived Neurotrophic FactorCyclic AMPCyclic AMP Response Element-Binding ProteinDendritesDepressionFluoxetineHippocampusMalePiperidinesPyramidal CellsPyridonesRats, Sprague-DawleySelective Serotonin Reuptake Inhibitors1-(1-benzyl-4-hydroxypiperidin-4-ylmethyl)-2(1H)-pyridinoneAnti-Anxiety AgentsAntidepressive AgentsBrain-Derived Neurotrophic FactorCyclic AMPCyclic AMP Response Element-Binding ProteinFluoxetinePiperidinesPyridonesSelective Serotonin Reuptake InhibitorsSerotonin 5-HT1 Receptor Agonists

Identifiers

PMID28858297
PMCPMC5758671
OpenAlexW2752054736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.